Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Patients need to be educated in proper injection techniques to prevent infection or injury and proper storage of vials to maintain drug potency
Abstract Tirzepatide, a dual agonist for glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, has shown robust efficacy in treating diabetes and obesity, and in obese patients with heart failure with preserved ejection fraction (HFpEF), it reduced weight, lowered blood pressure, and improved outcomes
Made with 100% certified renewable electricity
Handling Notes Do not refreeze
US$ 28.29
US$ 24.02
US$ 24.40
US$ 22.59
US$ 22.69
US$ 21.28
US$ 26.53
